In this Grand Rounds presentation, medical oncologist David Ilson talks about developments in adjuvant therapies for gastric cancer.
Significant progress in treating gastric cancer has been made in recent years due to improved staging, advances in surgical technology, and a deeper understanding of the heterogeneity of the disease.
Dr. Ilson describes the results of recent studies on the use of adjuvant radiation and chemotherapy in treating the illness. He discusses the latest research findings in PET scan imaging to tailor adjuvant treatments, and progress in targeted therapies. Gastric cancer is now recognized as three different diseases (proximal intestinal, distal intestinal, and diffuse) with distinct molecular signatures, enabling us to treat gastric cancer patients with multimodal therapies more tailored to their specific disease.